Kanaly Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$108K Buy
1,512
+192
+15% +$14.3K 0.02% 197
2016
Q3
$104K Sell
1,320
-2,180
-62% -$177K 0.02% 200
2016
Q2
$292K Sell
3,500
-40
-1% -$3.55K 0.06% 121
2016
Q1
$325K Buy
3,540
+222
+7% +$20K 0.07% 111
2015
Q4
$336K Buy
3,318
+45
+1% +$4.68K 0.07% 112
2015
Q3
$321K Sell
3,273
-236
-7% -$26.2K 0.07% 111
2015
Q2
$411K Buy
3,509
+430
+14% +$47K 0.08% 112
2015
Q1
$302K Sell
3,079
-4,892
-61% -$497K 0.06% 135
2014
Q4
$751K Buy
7,971
+200
+3% +$20.7K 0.15% 75
2014
Q3
$827K Sell
7,771
-107
-1% -$10.5K 0.16% 73
2014
Q2
$653K Sell
7,878
-4,298
-35% -$335K 0.12% 96
2014
Q1
$863K Buy
12,176
+603
+5% +$47.3K 0.17% 79
2013
Q4
$869K Buy
+11,573
New +$806K 0.17% 75

Other funds holding GILD

Kanaly Trust's GILD Position: Q4 2016 in Review

Kanaly Trust increased its Gilead Sciences (GILD) stake by 15% in Q4 2016, buying an estimated $14.3K and bringing the position to 1,512 shares worth $108K. The position accounts for 0.02% of the portfolio, ranked #197.

Kanaly Trust first reported a position in GILD in Q4 2013 and has held it in 13 quarters since. The position peaked at $869K in Q4 2013. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Kanaly Trust held 1,512 shares of Gilead Sciences worth $108K as of Q4 2016.
  • Kanaly Trust bought 192 Gilead Sciences shares in Q4 2016, an estimated $14.3K.
  • Gilead Sciences made up 0.02% of Kanaly Trust's portfolio in Q4 2016, its #197 holding.
  • Kanaly Trust first reported a position in Gilead Sciences in Q4 2013 and has held it in 13 quarters since.
  • Kanaly Trust's Gilead Sciences position peaked at $869K in Q4 2013.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.